Clinical Trials Browser

Phase 1/2 × Kidney Neoplasms × talazoparib × Clear all

NCT04337970 2025-05-28

Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

Phase 1/2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms